FDA Approved: SIGNIFOR LAR — Supplemental Application (Recordati Rare Diseases, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SIGNIFOR LAR (pasireotide) submitted by Recordati Rare Diseases, Inc., to modify the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Cushing Disease

Drugs mentioned

• SIGNIFOR LAR (PASIREOTIDE)

Snippet

SUPPL AP for SIGNIFOR LAR (PASIREOTIDE)